Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |